Sanofi
SNYNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $44 | $46 | $40 | $39 |
| % Growth | -4.6% | 15.2% | 2.9% | – |
| Cost of Goods Sold | $13 | $14 | $14 | $12 |
| Gross Profit | $31 | $32 | $32 | $27 |
| % Margin | 70.2% | 69.3% | 78.6% | 68.7% |
| R&D Expenses | $7 | $7 | $7 | $6 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9 | $11 | $9 | $10 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $7 | $7 | $0 | $4 |
| Operating Expenses | $24 | $24 | $15 | $19 |
| Operating Income | $14 | $13 | $13 | $8 |
| % Margin | 32.6% | 27.9% | 32.6% | 20.7% |
| Other Income/Exp. Net | $0 | -$7 | -$3 | -$0 |
| Pre-Tax Income | $7 | $6 | $10 | $8 |
| Tax Expense | $1 | $1 | $2 | $2 |
| Net Income | $6 | $5 | $8 | $6 |
| % Margin | 12.6% | 11.6% | 20.8% | 15.9% |
| EPS | 4.45 | 4.3 | 6.69 | 4.97 |
| % Growth | 3.5% | -35.7% | 34.6% | – |
| EPS Diluted | 4.43 | 4.3 | 6.66 | 4.95 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $4 | $3 | $3 | $3 |
| EBITDA | $11 | $11 | $14 | $11 |
| % Margin | 24.9% | 23.8% | 33.5% | 28.7% |